Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

Clinical trial NCT03057626 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03057626
Sponsor: Children's Oncology Group
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Recurrent Neuroblastoma Stage 2A Neuroblastoma Stage 2B Neuroblastoma Stage 3 Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma

Start date: 2017-06-05
Primary completion: 2021-09-30
Enrollment: 376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.